Scientists want to enhance our capacity to detect individuals at elevated risk, customize treatment approaches, and ultimately improve the quality of life for those affected by ischemic stroke by investigating the correlation between serum albumin levels and stroke outcomes. This evidence concerns the gene ALB and ischemic stroke.